This Viewpoint explores the possibility that data from published trials have been used to bolster the sales of a pemetrexed for use in nonsquamous non–small-cell lung cancer.
from Cancer via ola Kala on Inoreader http://ift.tt/2D1HR0Z
via IFTTT
Cancer Medicine by Alexandros G.Sfakianakis,Anapafseos 5 Agios Nikolaos,Crete 72100,Greece,tel :00302841026182 & 00306932607174
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου